WallStSmart
ZURA

Zura Bio Limited Class A Ordinary Shares

NASDAQ: ZURA · HEALTHCARE · BIOTECHNOLOGY

$5.31
-4.15% today

Updated 2026-07-29

Market cap
$517.10M
P/E ratio
P/S ratio
EPS (TTM)
$-1.09
Dividend yield
52W range
$1 – $7
Volume
1.2M

WallStSmart proprietary scores

28
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.3
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
1.2
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$15.67
+195.10%
12-Month target
Intrinsic (DCF)
Margin of safety
1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths
Insufficient data
Risks
- Piotroski 1/9 — weak financial health
- Altman Z 1.21 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-18.94M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-25.74M$-60.36M$-52.40M$-68.65M$-24.22M
EPS$-1.09
Free cash flow$-13.20M$-23.05M$-28.15M$-64.93M$-18.94M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
ZURA$517.10M284.33.05.05.3Avoid
LLY$1.02T7610.010.04.36.0Strong Buy
JNJ$615.36B574.78.54.36.0Buy
ABBV$447.53B634.08.04.75.0-78.83%Buy
UNH$391.69B627.35.54.06.0-30.51%Buy
MRK$307.25B503.38.02.75.0-62.28%Hold

Smart narrative

Zura Bio Limited Class A Ordinary Shares trades at $5.31. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 1.21, it sits in the distress.

Frequently asked questions

What is Zura Bio Limited Class A Ordinary Shares's stock price?

Zura Bio Limited Class A Ordinary Shares (ZURA) trades at $5.31.

Is Zura Bio Limited Class A Ordinary Shares overvalued?

Zura Bio Limited Class A Ordinary Shares carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Zura Bio Limited Class A Ordinary Shares (ZURA)?

The 12-month analyst consensus target is $15.67, about 195.1% above the current $5.31. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Zura Bio Limited Class A Ordinary Shares's Altman Z-Score is 1.21, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-34.78%
Beta-0.04
50D MA$4.50
200D MA$4.92
Shares out0.09B
Float0.05B
Short ratio
Avg volume1.2M

Performance

1 week-0.37%
1 month-4.44%
3 months+7.39%
YTD+2.67%
1 year
3 years
5 years